Latest Trials Focused on DRM, BPS, Cloud-Delivered 3.0, and More
June 7, 2025 - 02:03
In a significant advancement for the broadcasting industry, a recent event showcased the latest trials in NextGen TV technology, focusing on key areas such as Digital Rights Management (DRM), Broadcast Packetized Stream (BPS), and cloud-delivered services. These trials are designed to enhance the viewing experience and ensure seamless content delivery in the evolving landscape of digital media.
The event brought together industry leaders and innovators to demonstrate the capabilities of the NextGen TV ecosystem. Attendees had the opportunity to witness firsthand the integration of advanced technologies that promise to revolutionize how content is consumed. The emphasis on DRM is particularly crucial, as it addresses the growing concerns around content protection in an increasingly digital world.
Additionally, the exploration of BPS and cloud-delivered solutions highlights a shift towards more flexible and scalable broadcasting methods. As the industry continues to evolve, these trials mark a pivotal step in the journey toward a more dynamic and efficient broadcasting future.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...